Dr. Monika Fischer
Claim this profileIndiana University
Studies Crohn's Disease
Studies Ulcerative Colitis
12 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Monika Fischer is currently running
TAK-062
for Celiac Disease
This trial tests TAK-062, a drug that breaks down gluten, in people with celiac disease who are on a gluten-free diet. The goal is to see if TAK-062 can reduce symptoms and intestinal damage caused by accidental gluten exposure.
Recruiting0 awards Phase 26 criteria
Mirikizumab
for Crohn's Disease
This trial is testing mirikizumab to see if it can help people with Crohn's disease feel better over a long time and ensure it is safe. The drug works by reducing gut inflammation.
Recruiting2 awards Phase 3
More about Monika Fischer
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Monika Fischer has experience with
- Placebo
- ABX464
- Ozanimod
- Mirikizumab
- BMS-986165
- Ustekinumab
Breakdown of trials Monika Fischer has run
Crohn's Disease
Inflammatory Bowel Disease
Granulomatous Enteritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Monika Fischer specialize in?
Monika Fischer focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Monika Fischer currently recruiting for clinical trials?
Yes, Monika Fischer is currently recruiting for 6 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Monika Fischer has studied deeply?
Yes, Monika Fischer has studied treatments such as Placebo, ABX464, Ozanimod.
What is the best way to schedule an appointment with Monika Fischer?
Apply for one of the trials that Monika Fischer is conducting.
What is the office address of Monika Fischer?
The office of Monika Fischer is located at: Indiana University, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.